Progressive looks to reduce price further for $345m Bonanza Re 2024-1 cat bond – Go Health Pro

Progressive looks to reduce price further for 5m Bonanza Re 2024-1 cat bond – Go Health Pro

US insurance firm Progressive is targeting even more favourable price execution for its latest venture to the catastrophe bond market, with the spread guidance for its new $345 million Bonanza Re Ltd. (Series 2024-1) issuance having fallen further in the latest update, we understand.Progressive returned to the cat bond market in late November, with what … Read more

2025 Housing Price Forecasts: Continued Strong Gains – Go Health Pro

2025 Housing Price Forecasts: Continued Strong Gains – Go Health Pro

Now that I’ve shared the 2025 S&P 500 target price forecast, let’s dive into housing price forecasts for 2025. The outlook from housing analysts is positive, with expected gains ranging from -0.4% to 10.8%, and an average of about 3%. The only negative housing price forecast comes from Moody’s, which predicts a slight decline of -0.4% largely … Read more

Zacks Small Cap Research – MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00. – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 3rd quarter 2024 financial results on November 14th which were largely in line with expectations. Research and development expenses for the quarter ending September 30, 2024 were $2.2 million compared to $2.7 million in the prior year period. The R&D decrease … Read more

Price reductions to be determined on the basis of the ‘prior price’ (C-330/23 Aldi Süd) – Go Health Pro

Price reductions to be determined on the basis of the ‘prior price’ (C-330/23 Aldi Süd) – Go Health Pro

 Guest post by Laura Bakola (PhD candidate at Leiden University) In September the CJEU issued a judgment on price indications and the obligation of the trader to announce a price reduction on the basis of the ‘prior price’ of the product. The case comes after the amendment introduced by Directive 2019/2161, as regards the better … Read more

Zacks Small Cap Research – TWI: Titan International Free Cash Flow Generation Over the Long Term Supports Price Target of $16.00 – Go Health Pro

By Thomas Kerr, CFA NYSE:TWI READ THE FULL TWI RESEARCH REPORT 3rd Quarter 2024 Financial and Operating Results Titan International (NYSE:TWI) reported 3rd quarter 2024 financial results which continued to reflect a difficult macro environment in most of its end markets as the OEM destocking story continues to evolve. Net sales for the 3rd quarter … Read more

x